Publisher's Synopsis
340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties (US Department of Health and Human Services Regulation) (HHS) (2018 Edition) The Law Library presents the complete text of the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties (US Department of Health and Human Services Regulation) (HHS) (2018 Edition). Updated as of May 29, 2018 The Health Resources and Services Administration (HRSA) administers section 340B of the Public Health Service Act (PHSA), referred to as the "340B Drug Pricing Program" or the "340B Program." This final rule will apply to all drug manufacturers that are required to make their drugs available to covered entities under the 340B Program. This final rule sets forth the calculation of the 340B ceiling price and application of civil monetary penalties (CMPs). This book contains: - The complete text of the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties (US Department of Health and Human Services Regulation) (HHS) (2018 Edition) - A table of contents with the page number of each section
